Skip to main content

Table 2 IVF cycle characteristics of patients

From: Potential ability of circulating INSL3 level for the prediction of ovarian reserve and IVF success as a novel theca cell–specific biomarker in women with unexplained infertility and diminished ovarian reserve

Variables

Unexplained

(n = 24)

DOR

(n = 25)

Control

(n = 26)

p value

Total dosage of gonadotropins (IU)

Maximum estradiol levels (pg/mL)

1831.25 ± 554.19

2220.58 ± 739.21

2193.00 ± 625.72

724.08 ± 405.72

1817.30 ± 527.05

2350.00 ± 746.43

0.093

< 0.001*

Duration of stimulations (day)

7.62 ± 1.13

8.76 ± 1.42

8.11 ± 1.39

0.017*

Number of oocytes retrieved

Number of mature follicles retrieved

Number of PN

11.08 ± 3.77

9.58 ± 3.79

7.37 ± 3.56

3.72 ± 1.79

2.92 ± 1.38

1.92 ± 1.03

11.73 ± 3.02

10.53 ± 2.95

7.69 ± 2.49

< 0.001*

< 0.001*

< 0.001*

Endometrial thickness at day of transfer (mm)

8.27 ± 1.17

15.47 ± 23.96

7.99 ± 1.07

0.155

  1. All values are expressed as mean±Standard Deviation. *p < 0.05, significant difference
  2. IVF: In vitro fertilizasyon
  3. DOR: Diminished ovarian reserve
  4. PN: Pronucleus